Journal of Advances in Clinical Nursing

Objective To analyze the clinical effect of low molecular weight heparin in the treatment of recurrent abortion after pregnancy obtained by human assisted reproductive technology. Methods A total of 100 patients with recurrent abortion after receiving human assisted reproductive technology treatment in our hospital from January 2023 to January 2024 were selected as the study objects, and they were divided into control group (50 cases, routine fetal preservation treatment) and observation group (50 cases, clinical treatment) according to random grouping method. The pregnancy outcome, coagulation function index, incidence of adverse reactions and pregnancy-related hormone levels of the two groups were compared and evaluated. Results The average levels of D-dimer and fibrinogen in observation group were lower than those in control group (P < 0.05). The incidence of adverse reactions in observation group was lower than that in control group (P < 0.05). The levels of progesterone, human chorionic gonadotropin and estradiol in observation group were higher than those in control group (P < 0.05). The abortion rate in observation group was lower than that in control group (P < 0.05), and the premature birth rate was lower than that in control group (P > 0.05). Conclusion The treatment of low molecular weight heparin in the patients with pregnancy and recurrent abortion after receiving assisted reproductive technology has achieved obvious effect, significantly improving the hormone level and coagulation function index of patients, and reducing the incidence of adverse reactions and abortion rate, which has high application value.

Low molecular weight heparin; Human assisted reproductive technology; Recurrent abortion; Pregnancy